rs140936359
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_ModerateBP6_Very_StrongBS2
The NM_013995.2(LAMP2):āc.1135A>Gā(p.Ile379Val) variant causes a missense change. The variant allele was found at a frequency of 0.00025 in 1,208,250 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 79 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 10/14 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Consequence
NM_013995.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LAMP2 | NM_002294.3 | c.1093+2478A>G | intron_variant | ENST00000200639.9 | NP_002285.1 | |||
LAMP2 | NM_013995.2 | c.1135A>G | p.Ile379Val | missense_variant | 9/9 | NP_054701.1 | ||
LAMP2 | NM_001122606.1 | c.1093+2478A>G | intron_variant | NP_001116078.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LAMP2 | ENST00000200639.9 | c.1093+2478A>G | intron_variant | 1 | NM_002294.3 | ENSP00000200639.4 |
Frequencies
GnomAD3 genomes AF: 0.000134 AC: 15AN: 111738Hom.: 0 Cov.: 23 AF XY: 0.0000884 AC XY: 3AN XY: 33918
GnomAD3 exomes AF: 0.0000873 AC: 16AN: 183320Hom.: 0 AF XY: 0.0000737 AC XY: 5AN XY: 67822
GnomAD4 exome AF: 0.000262 AC: 287AN: 1096512Hom.: 0 Cov.: 28 AF XY: 0.000210 AC XY: 76AN XY: 361956
GnomAD4 genome AF: 0.000134 AC: 15AN: 111738Hom.: 0 Cov.: 23 AF XY: 0.0000884 AC XY: 3AN XY: 33918
ClinVar
Submissions by phenotype
Danon disease Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Victorian Clinical Genetics Services, Murdoch Childrens Research Institute | Feb 02, 2022 | Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Likely benign. Following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with Danon disease (MIM#300257). (I) 0110 - This gene is associated with X-linked dominant disease. (I) 0115 - Variants in this gene are known to have variable expressivity. Phenotypic variability has been described, and males typically have earlier disease onset and more severe phenotypes than females (OMIM). (I) 0200 - Variant is predicted to result in a missense amino acid change from isoleucine to valine. (I) 0251 - This variant is heterozygous. (I) 0302 - Variant is present in gnomAD (v2) <0.001 for a dominant condition (12 heterozygotes, 0 homozygotes, 5 hemizygotes). (SP) 0503 - Missense variant consistently predicted to be tolerated by multiple in silico tools or not conserved in placental mammals with a minor amino acid change. (SB) 0604 - Variant is not located in an established domain, motif, hotspot or informative constraint region. (I) 0705 - No comparable missense variants have previous evidence for pathogenicity. (I) 0808 - Previous reports of pathogenicity for this variant are conflicting. This variant has been reported as VUS and benign in ClinVar. It has also been reported as VUS in an individual with atrial fibrillation who also has a pathogenic KCNQ1 variant (PMID:31638414) and an individual with HCM who also has a likely pathogenic MYH7 variant (VCGS). (I) 0905 - No published segregation evidence has been identified for this variant. (I) 1007 - No published functional evidence has been identified for this variant. (I) 1208 - Inheritance information for this variant is not currently available in this individual. (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 08, 2021 | - - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Dec 11, 2019 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at